Proxifen® 23 L.A.
Clinical trial of the application of Proxifen® 23 L.A. (association of oxytetracycline and ketoprofen) subcutaneously in the treatment of canine Ehrlichiosis
Clinical trial of the application of Proxifen® 23 L.A. (association of oxytetracycline and ketoprofen) subcutaneously in the treatment of canine Ehrlichiosis
Determination of the residence time in blood of an injectable solution of Enrofloxacin in a long-acting vehicle (Enroflox® 20 L.A.) after a single intramuscular application in fattening cattle
Evaluation of the presence of antibiotic residues from cow's milk with a single intramammary application of the product Cefa Milk® Forte
Evaluation of the effectiveness of a 30% Oxytetracycline Injectable Solution (Duramycin® 300 L.A.) in the prevention of the clinical presentation of shipping fever in intensively rearing beef cattle
Effectiveness and Tolerance of the Injectable Antibiotic (Duramycin® 300 L.A.) Oxytetracycline at 30% in the treatment of bacterial pneumonia in intensively farmed Fattening Cattle
Evaluation of the Bacteriostatic Effectiveness of an Injectable Solution based on 30% Oxytetracycline dihydrate (Duramycin® 300 L.A.) and its permanence in plasma in cattle.
Residue detection of a commercial antibiotic suspension based on Ceftiofur hydrochloride (Cefa-Ject®) in dairy cattle
Detection of Residues of a commercial antibiotic infusion based on Cephalexin monohydrate and Gentamicin sulfate (Cefa-Milk®Forte) in cow's milk.